These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 683868)

  • 21. [The intracerebral distribution of bismuth in bismuth encephalopathy. Pathological and toxicological study of 3 cases (author's transl)].
    Ribadeau Dumas JL; Lechevalier B; Breteau M; Allain Y
    Nouv Presse Med; 1978 Dec; 7(44):4021-5. PubMed ID: 733570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and electroencephalographic aspects of encephalopathy caused by insoluble bismuth salts. Apropos of 9 cases].
    Mabin D; Bedou G; Tuset MC
    Sem Hop Ther; 1976 Feb; 52(2):109-16. PubMed ID: 982067
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bismuth myoclonic encephalopathy. Report of two cases (author's transl)].
    Cervelló MA; Alfaro A; Antolín MA; Peñarrocha M
    Med Clin (Barc); 1982 Jul 1-31; 79(3):137-40. PubMed ID: 7109770
    [No Abstract]   [Full Text] [Related]  

  • 24. [Encephalopathy after oral ingestion of bismuth salt over a short time period (10 days)].
    Davous P; Bouche P; Derouesne C; Castaigne P
    Nouv Presse Med; 1977 Oct; 6(36):3336. PubMed ID: 593865
    [No Abstract]   [Full Text] [Related]  

  • 25. [Letter: Reversible acute myoclonic encephalopathies after bismuth salt ingestion].
    Fressinaud L; Emile J; Charbonnel A; Féve JR
    Nouv Presse Med; 1975 Mar; 4(12):885. PubMed ID: 1136684
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bismuth encephalopathies outside France (author's transl)].
    Lagier G
    Therapie; 1980; 35(3):315-7. PubMed ID: 7423419
    [No Abstract]   [Full Text] [Related]  

  • 27. [Bismuth preparations--encephalopathy].
    Myren J; Sigstad H
    Tidsskr Nor Laegeforen; 1978 Feb; 98(6):333. PubMed ID: 635868
    [No Abstract]   [Full Text] [Related]  

  • 28. [Epidemiological aspects of the encephalopathies resulting from oral administration of bismuth (author's transl)].
    Martin-Bouyer G; Foulon B; Guerbois H; Barin C
    Therapie; 1980; 35(3):307-13. PubMed ID: 7423418
    [No Abstract]   [Full Text] [Related]  

  • 29. [Letter: Encephalopathies during treatment with bismuth or the mishaps of"conjugated" bismuth therapy].
    Raverdy P; Smagghe A; Marie JP; Prinseau J
    Nouv Presse Med; 1975 Apr; 4(14):1050. PubMed ID: 805409
    [No Abstract]   [Full Text] [Related]  

  • 30. [20 cases of acute encephalopathy with myoclonus during treatments with orally-administered bismuth salts].
    Buge A; Rancurel G; Poisson M; Gazengel J; Dechy H; Fressinaud L; Emile J
    Ann Med Interne (Paris); 1974 Dec; 125(12):877-88. PubMed ID: 4469951
    [No Abstract]   [Full Text] [Related]  

  • 31. [Too much bismuth].
    Barbizet J; Degos JD; Lamotte J
    Ann Med Interne (Paris); 1978 Jan; 129(1):77-80. PubMed ID: 637465
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bismuth encephalopathy. Presentation of a case].
    Fernández Barreiro A; Sicilia Guillén J; Castejón Vera P; Escribano Soriano JB; Bautista Prados JG; Díaz Ortuño A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1983; 11(2):127-32. PubMed ID: 6880891
    [No Abstract]   [Full Text] [Related]  

  • 33. [Semiology of bismuth encephalopathy. Comparison with seven personal cases (author's transl)].
    Collignon R; Bruyer R; Rectem D; Indekeu P; Laterre EC
    Acta Neurol Belg; 1979; 79(2):73-91. PubMed ID: 484202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relationship between the course of bismuth encephalopathy and the amount of bismuth in blood and urine].
    Boiteau HL; Cler JM; Mathé JF; Delobel R; Fève J
    Eur J Toxicol Environ Hyg; 1976; 9(4):233-9. PubMed ID: 976332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Letter: Myoclonic encephalopathies caused by bismuth salts].
    Tournilhac M; Flori B; Dordain G; Roye JM
    Nouv Presse Med; 1975 Feb; 4(6):430. PubMed ID: 1129100
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study of the bismuth effect on bacteria, specially on faecal flora (author's transl)].
    Joly B; Petit S; Laveran H; Cluzel R
    Ann Pharm Fr; 1980; 38(1):75-80. PubMed ID: 7396344
    [No Abstract]   [Full Text] [Related]  

  • 37. [Letter: Acute bismuth induced encephalopathy in a pregnant woman. Birth of a normal child].
    Hervet E; Barrat J; Darbois Y; Faguer C; Véron P
    Nouv Presse Med; 1975 Sep; 4(31):2274-5. PubMed ID: 1237128
    [No Abstract]   [Full Text] [Related]  

  • 38. [Bismuth myoclonic encephalopathies. Their course and lasting or definitive late complications].
    Buge A; Rancurel G; Dechy H
    Rev Neurol (Paris); 1977; 133(6-7):401-15. PubMed ID: 929035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bismuth-induced encephalopathy].
    Caron JC; Prudhomme M; Warot P
    Lille Med; 1977 Feb; 22(2):98-100. PubMed ID: 865243
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic trial of a combination of an insoluble bismuth salt and a Karaya gum in gastrointestinal disorders].
    Héraud M; Paris JC
    Lille Med; 1969; ():677-9. PubMed ID: 5404535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.